Free Trial
NASDAQ:AVR

Anteris Technologies Global Q1 2025 Earnings Report

Anteris Technologies Global logo
$3.28 -0.02 (-0.61%)
As of 04:00 PM Eastern

Anteris Technologies Global EPS Results

Actual EPS
-$0.61
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Anteris Technologies Global Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Anteris Technologies Global Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Tuesday, May 13, 2025
Conference Call Time
6:00PM ET

Upcoming Earnings

Anteris Technologies Global's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025

Earnings Documents

Anteris Technologies Global Earnings Headlines

Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.
See More Anteris Technologies Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email.

About Anteris Technologies Global

Anteris Technologies Global (NASDAQ:AVR) engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

View Anteris Technologies Global Profile

More Earnings Resources from MarketBeat